Evidence map›Paper›PMID 33198810›Full record

ArticleRadiation oncology (London, England)2020

Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy.

Lucas Basler, Robert Poel, Christina Schröder, Alessandra Bolsi, Antony Lomax, Stephanie Tanadini-Lang, Matthias Guckenberger, Damien C Weber

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lucas BaslerCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland. Lucas.Basler@psi.ch.ORCID http://orcid.org/0000-0003-1259-5825
Robert PoelCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland.
Christina SchröderCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland.
Alessandra BolsiCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland.
Antony LomaxCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland.
Stephanie Tanadini-LangDepartment of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Matthias GuckenbergerDepartment of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Damien C WeberCenter for Proton Therapy, Paul Scherrer Institute, ETH Domain, Forschungsstrasse 111, 5232, Villigen, Switzerland.
Paul Scherrer Institute · CHUniversity of Zurich · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite combined modality treatment involving surgery and radiotherapy, a relevant proportion of skull-base chordoma and chondrosarcoma patients develop a local recurrence (LR). This study aims to analyze patterns of recurrence and correlate LR with a detailed dosimetric analysis.

methods222 patients were treated with proton radiotherapy for chordoma (n = 151) and chondrosarcoma (n = 71) at the PSI between 1998 and 2012. All patients underwent surgery, followed by pencil-beam scanning proton therapy to a mean dose of 72.5 ± 2.2Gy

resultsAfter a median follow-up of 50 months, 35 (16%) LR were observed. Follow-up MRI imaging was available for 27 (77%) of these recurring patients. Only one (3.7%) recurrence was located completely outside the initial PTV (surgical pathway recurrence). The mean proportions of LR covered by the initial target structures were 48% (range 0-86%) for the GTV, 70% (range 0-100%) for PTV

conclusionThis study identified DVH parameters, which are associated with the risk of local recurrence after proton therapy using pencil-beam scanning for patients with skull-base chordoma and chondrosarcoma.

Indexed as

AdultChondrosarcomaChordomaFemaleHumansMaleMiddle AgedProton TherapyRadiotherapy DosageRetrospective StudiesSkull Base NeoplasmsTreatment FailureChondrosarcomaChordomaDosimetric analysisPatterns of recurrencePencil beam scanning proton therapyProton therapySkull-base

Identifiers

PMID33198810
PMCPMC7670611
OpenAlexW3100433221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.